Pmv Pharmaceuticals Inc (PMVP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $89.89M
Last updated: Nov 17, 2026 at 4:10 PM ET
Pmv Pharmaceuticals Inc (PMVP) Statistics
Pmv Pharmaceuticals (PMVP) has a market cap of $89.89M and an enterprise value of $69.89M. Its share count is up 24.98% from a year earlier. It holds $19.99M more cash than debt, 22.24% of its market cap.
Total Valuation
Enterprise value is 22.24% below the market cap, as cash exceeds debt.
| Market Cap | $89.89M |
|---|---|
| Enterprise Value | $69.89M |
| Latest price (Nov 17, 2026) | $1.22 |
Key Dates
The next earnings report is expected on Mar 4, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 4, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 10, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 11.59% over 52 weeks and trades 11.59% below its 50-day average.
| Beta (1Y) | 0.71 |
|---|---|
| 52-Week Change | -11.59% |
| 1-Month Change | -2.79% |
| 3-Month Change | -4.69% |
| 6-Month Change | -6.87% |
| 5-Year Change | -94.45% |
| Total Return (1Y) | -11.59% |
| Total Return (3Y CAGR) | -21.27% |
| Total Return (5Y CAGR) | -45.09% |
| Return vs SPY (1Y) | -24.42% |
| Max Drawdown (1Y) | -41.67% |
| Max Drawdown (3Y) | -74.29% |
| Sharpe Ratio (1Y) | -0.20 |
| Correlation with SPY (1Y) | 0.14 |
| 50-Day Average | $1.38 |
| 200-Day Average | $1.31 |
| 52-Week Range | $1.02 to $1.91 |
| RSI (14 Days) | 44.4 |
| Average Volume (20 Days) | 416.49K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 9.81x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 9.81x |
|---|---|
| Quick Ratio | 9.81x |
| Debt / Equity | 0.00x |
| Interest Coverage | 24.11x |
Returns and Efficiency
Return on equity is -155.03% over the last 12 months, against a 5-year average of -37.34%.
| Return on Equity (ROE) | -155.03% |
|---|---|
| Return on Assets (ROA) | -79.47% |
| ROE (5Y Average) | -37.34% |
| ROA (5Y Average) | -33.86% |
| ROIC (5Y Average) | -80.09% |
Scores
PMVP has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Gross Profit | -$33.00K |
| Operating Income | -$77.20M |
| Pretax Income | -$88.51M |
| Net Income | -$88.53M |
| Reported EPS (TTM) | -$1.31 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 51.27% of the $111.40M in total assets.
| Cash and Equivalents | $19.99M |
|---|---|
| Total Debt | $0 |
| Net Cash | $19.99M |
| Net Cash Per Share | $0.30 |
| Working Capital | $94.20M |
| Shareholder Equity | $57.11M |
| Book Value Per Share | $0.86 |
| Total Assets | $111.40M |
| Total Liabilities | $54.30M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$69.63M |
|---|---|
| FCF Per Share | -$0.92 |
| Depreciation and Amortization | $1.83M |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | -33.07% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -33.07% |
Dividends and Yields
PMVP does not pay a dividend.
| Buyback Yield | -63.31% |
|---|---|
| Shareholder Yield | -63.31% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About PMVP
What is PMVP's market cap?
Pmv Pharmaceuticals has a market cap of $89.89M. Its enterprise value, which adds debt and subtracts cash, is $69.89M.
How many shares of PMVP are outstanding?
Pmv Pharmaceuticals has 66.23M shares outstanding. The count is up 24.98% from a year earlier.
Does PMVP pay a dividend?
No. Pmv Pharmaceuticals does not pay a dividend.
How much debt does PMVP have?
Pmv Pharmaceuticals has $0 of total debt and $19.99M of cash and equivalents, a net cash position of $19.99M.
PMVP pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors